About Gradalis
Gradalis is a private company based in Carrollton, Texas. It has reported $56,661,167 raised in two offerings on Form D since April 2018.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 5, 2025 | Jun 12, 2025 | $12,725,000of $30.0M target | 24 | $530K | Debt, Options, Common StockRule 506(b) | Form D ↗ |
| Mar 16, 2018 | Apr 2, 2018 | $43,936,167of $55.0M target | 36 | $1.2M | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $56,661,167 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Gradalis's Form D filed Jun 12, 2025.
Earlier filings also listed Thomas Lyles (director, last listed Apr 2018), Renee Larson (executive officer, last listed Apr 2018), John Nemunaitis, M.D. (executive officer and director, last listed Apr 2018), Joe Cunningham, M.D. (director, last listed Apr 2018), Harry Jacobson, M.D. (director, last listed Apr 2018), Gladice Wallraven (executive officer, last listed Apr 2018) and Ernest Bognar (executive officer, last listed Apr 2018).